PULSE the living trend engine
🤖 Open Intelligence Dossier available for AI agents & citation View Markdown (.md) →
◼ Archived Health

'Good' Body Fat Is Linked to Fewer Anxiety And Depression Diagnoses

A widely prescribed blood pressure drug increased calorie-burning brown fat in mice, according to a recent study.

6sources
6articles
4velocity
+84%since first seen
10d agofirst detected

Velocity

How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →

The brief

A widely prescribed blood pressure pill increased the activity of heat-producing brown fat in mice, raising their energy use without changing their body weight, according to a study in Nature led by researchers at Rockefeller University and Memorial Sloan Kettering Cancer Center. Nature World News reported that the finding grew out of a huge review of hospital scans, which showed that patients taking losartan and a related drug were slightly more likely to have detectable brown fat. That pattern was only an association, and no clinical trial has tested whether losartan activates brown fat in people. Most body fat is white fat, which stores energy, while brown fat burns sugar and fat to generate heat. Scientists once thought adults lost nearly all their brown fat after infancy, but imaging studies over the past two decades showed many adults still carry small deposits around the neck, collarbone, armpits, and spine. Cold exposure is the best-known natural way to activate it. UA.NEWS reported that researchers analyzed the medical records of more than 100,000 patients at Memorial Sloan Kettering Cancer Center in New York and found an association between detected brown adipose tissue and less frequently recorded diagnoses of anxiety disorders and depressive episodes. In the group with detected tissue, 5.4 percent of patients had a diagnosis of a depressive episode, compared with 8.2 percent in the group without it, according to UA.NEWS. Earth.com reported that the team pulled every scan from Memorial Sloan Kettering between 2018 and 2024, adding them to an earlier set for a total of 101,243 patients. Brown fat appeared on at least one scan in 8,897 of them, just under 9 percent. Each patient with brown fat was matched to roughly two without it on age, sex, body mass index, and outdoor temperature on the scan day. Of 98 diagnoses that differed between the groups, 92 were less common in people with brown fat. The strongest were type 2 diabetes and chronic ischemic heart disease, while anxiety disorders and depression were also lower. First author Dr. Nicolás Gómez-Banoy said, 'We know that metabolically healthy people tend to have lower incidence of psychiatric diseases, so it could be that having brown fat makes you more metabolically healthy, and this correlates with fewer psychiatric issues.' The team checked 125 medications patients were taking a month before their scan. Losartan and its cousin valsartan came out on the positive side, with 2.4 percent of patients with brown fat taking losartan compared with 1.9 percent of those without it. Two kinds of drugs already known to dampen brown fat, beta blockers and SSRIs, came out on the negative side. Losartan lowers blood pressure by blocking the angiotensin receptor, but in brown fat cells the drug still worked after that receptor was knocked down, pointing to a separate pathway. The published paper reports that losartan switched on a fat-cell master regulator called PPAR-gamma and its heat-producing gene program. Mice given losartan in their drinking water burned more energy and used more oxygen at room temperature and in a cold chamber, while their weight and activity stayed the same. The researchers say prospective human studies are needed before anyone can say whether losartan's brown fat effect matters for patients. Paul Cohen, who heads Rockefeller's Laboratory of Molecular Metabolism, noted that the dataset flagged other medications worth studying as well. People already prescribed losartan should keep taking it as directed and raise any questions with their doctor or pharmacist, as starting, stopping, or changing a blood pressure drug without supervision can cause dangerous swings.

Synthesized by PULSE from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 8d ago.

Quick answers

What did the losartan study find regarding brown fat?

Losartan increased brown fat activity and energy use in mice and brown fat cells, and patient scans showed those taking losartan were slightly more likely to have detectable brown fat.

Does taking losartan cause weight loss?

No study has shown that, as mice given losartan burned more energy but did not lose weight, and no human trial has tested it.

What are the natural ways to activate brown fat?

Cold exposure is the best-known natural way to activate brown fat, and patient scans showed brown fat was detected more often on colder days.

Coverage (6)

Topics

Related trends

\n \n \n \n \n \n \n